| Literature DB >> 26336553 |
Takashi Kanda1, Masaharu Masuda1, Akihiro Sunaga1, Masashi Fujita1, Osamu Iida1, Shin Okamoto1, Takayuki Ishihara1, Kiyonori Nanto1, Tatsuya Shiraki1, Fusako Sera1, Masaaki Uematsu1.
Abstract
Fabry disease is an X-linked recessive glycosphingolipid storage disorder caused by a deficiency of lysosomal enzyme α-galactosidase A. It is recognized that Fabry disease patients often have ventricular arrhythmias. Although the effectiveness of implantable cardioverter-defibrillator (ICD) therapy in patients with ventricular fibrillation is established, there is little evidence regarding ICD therapy for Fabry disease. Here, we report the case of patient with Fabry disease who was treated with an ICD and presented with high defibrillation thresholds.Entities:
Keywords: Fabry disease; High defibrillation thresholds; Implantable cardioverter-defibrillator; Ventricular fibrillation
Year: 2014 PMID： 26336553 PMCID： PMC4550129 DOI： 10.1016/j.joa.2014.10.002
Source DB: PubMed Journal: J Arrhythm ISSN： 1880-4276